메뉴 건너뛰기
Library Notice
Institutional Access
If you certify, you can access the articles for free.
Check out your institutions.
ex)Hankuk University, Nuri Motors
Log in Register Help KOR
Subject
Humanities
General Humanities History Philosophy Religious Studies Linguistics and Literature Other Humanities
Social science
General Social Science Business Management Tourism Education Military Science Library and Information Science Law Sociology Journalism and Media Studies Psychological Science Political Science and Diplomacy Geography Public Administration Economics International Trade Anthropology Other Social Science
Natural science
General Natural Science Physics Biology Life Sciences Mathematics/Statistics Astronomy Earth Science Chemistry Other Natural Science
Engineering
General Engineering Architectural Engineering Mechanical Engineering Industrial Engineering Material/Energy Engineering Electrical and Electronic Engineering Marine and Ocean Engineering Chemical Engineering Computer Science Other Engineering
Medical science
General Medical Science Nursing Science Veterinary Pharmacy Traditional Korean Medicine Basic Medicine Clinical Medicine Other Medicine
Agriculture and Fishery
General Agriculture and Fishery Agriculture Fishery Science Food Science Forestry Animal Husbandry Marine Transportation Studies Other Agriculture and Fishery
Art and Kinesiology
General Arts Design Fine Arts Cosmetology Photography Music Fashion Kinesiology Performing Media Arts Other Arts and Kinesiology
Interdisciplinary Studies
Interdisciplinary Research Science and Technology Studies Brain and Cognitive Science Technology Policy Other Interdisciplinary Studies

KOR

Next-generation Vaccines for Infectious Viral Diseases
Recommendations
Search
Questions

차세대 감염병 백신

논문 기본 정보

Type
Academic journal
Author
Sun-Woo Yoon (국립안동대학교)
Journal
Korean Society Of Life Science Journal of Life Science Vol.33 No.9 KCI Accredited Journals
Published
2023.9
Pages
746 - 753 (8page)

Usage

DBpia Top 5%Percentile based on 2-year
usage in the same subject category.
cover
📌
Topic
📖
Background
🔬
Method
🏆
Result
Next-generation Vaccines for Infectious Viral Diseases
Ask AI
Recommendations
Search
Questions

Abstract· Keywords

Report Errors
Viral infectious diseases have been regarded as one of the greatest threats to global public health. The recent coronavirus disease 2019 (COVID-19) pandemic caused by the severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) is a stark reminder of the threat posed by emerging viral infections. Developing and producing appropriate and efficient vaccines and therapeutics are the only options to combat this pandemic. The COVID-19 pandemic has highlighted the need for novel vaccine platforms to control and prevent emerging viral diseases. Conventional vaccine platforms, including live-attenuated vaccine and inactivated vaccines, pose limitations in the speed of vaccine development, manufacturing capacity, and broad protection for emergency use. Interestingly, vaccination with the SARS-CoV-2 vaccine candidate based on the mRNA-lipid nanoparticle (LNP) platform protected against COVID-19, confirming that the nucleoside-modified candidate is a safe and effective alternative to conventional vaccines. Moreover, the prophylactic strategies against the COVID-19 pandemic have been mRNA nucleic acid-based vaccines and nanoparticle-based platforms, which are effective against SARS-CoV-2 and its variants. Overall, the novel vaccine platform has presented advantages compared with the traditional vaccine platform in the COVID-19 pandemic. This review explores the recent advancements in vaccine technologies and platforms, focusing on mRNA vaccines, digital vaccines, and nanoparticles while considering their advantages and possible drawbacks.
#Digital vaccine #infectious disease viruses #messenger RNA #nanoparticle vaccine nextgeneration vaccine

Contents

서론
본론
결론
References
초록

References (71)

Add References
Ai, L., Li, Y., Zhou, L., Yao, W., Zhang, H., Hu, Z., Han, J., Wang, W., Wu, J., Xu, P., Wang, R., Li, Z., Li, Z., Wei, C., Liang, J., Chen, H., Yang, Z., Guo, M., Huang, Z., Wang, X., Zhang, Z., Xiang, W., Sun, D., Xu, L., Huang, M., Lv, B., Peng, P., Zh google schola Allen, T. M. and Cullis, P. R. 2004. Drug delivery systems: entering the mainstream. Science 303, 1818-1822. google schola Anderluzzi, G., Lou, G., Gallorini, S., Brazzoli, M., Johnson, R., O'Hagan, D. T., Baudner, B. C. and Perrie, Y. 2020. Investigating the impact of delivery system design on the efficacy of self-amplifying RNA vaccines. Vaccines (Basel) 8, 212. google schola Anderson, B. R., Muramatsu, H., Nallagatla, S. R., Bevilacqua, P. C., Sansing, L. H., Weissman, D. and Karikó, K. 2010. Incorporation of pseudouridine into mRNA enhances translation by diminishing PKR activation. Nucleic Acids Res. 38, 5884-5892. google schola Arevalo, C. P., Bolton, M. J., Sage, V. L., Ye, N., Furey, C., Muramatsu, H., Alameh, M. -G., Pardi, N., Drapeau, E. M., Parkhouse, K., Garretson, T., Morris, J. S., Moncla, L. H., Tam, Y. K., Fan, S. H. Y., Lakdawala, S. S., Drew, W. and Hensley, S. E. 2 google schola

Recommendations

It is an article recommended by DBpia according to the article similarity. Check out the related articles!

Related Authors

Frequently Viewed Together

합성 mRNA 소개 및 백신으로서의 활용
임성은 ,  최보금 ,  조현진 and others 1 BT NEWS 2021 .04
mRNA 백신의 열적안정성 확보를 위한 최신 연구동향
정재환 BT NEWS 2023 .04
[정헌 애스톤사이언스 대표] DNA 기반 치료용 백신 개발
장봄이 ,  최영재 Forbes Korea 2023 .07
Artificial Intelligence-based Framework for Designing a Novel mRNA Vaccine
Hyunseung Kong ,  Inyoung Kim ,  Byoung-Tak Zhang 한국정보과학회 학술발표논문집 2023 .06
바이오 의약 소재
최종훈 한국생물공학회 학술대회 2021 .04

Recently viewed articles

A Study on the Establishment and Operations of Joint University - Focusing on Chinese Cases -
Lee, Young Hwan, Im 외 1명Education Research Institute2014.09
 Risk factors of postoperative ascites on hepatic resection for hepatocellular carcinoma
Seong Woon Choi, Woo Young Shin, Keon Young Lee 외 1명The Korean Association of HBP Surgery2016.11
 오직 한 사람의 차지
김금희2017.03
 조건 표현 ‘-(으)ㄴ/는 한’에 대한 연구- 한국어 교육의 측면에서 -
BACKSOOJIN, 목지선undefined2018

Comments(0)

0

Write first comments.

UCI(KEPA) : I410-151-24-02-088059085